Fig. 2From: Toward the personalized and integrative management of voriconazole dosing during COVID-19-associated pulmonary aspergillosisEmpirical algorithm for voriconazole dose adjustment in CAPA patients. CAPA COVID-19-associated pulmonary aspergillosis; PPI proton pump inhibitor; DXM dexamethasone; TDM therapeutic drug monitoring; CRP C-reactive protein; b.i.d twice a day; *: except for pantoprazoleBack to article page